GlassScriptPhysician profile
Todd M Weiss
NPI 1659593713
$3,216.07
in general payments reported to CMS, 2019-2025
20 companies · $572 in 2025
The $572 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,119 · 2020: $258 · 2021: $318 · 2022: $413 · 2023: $305 · 2024: $231 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,108.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $2,052.63 | 2019-2024 | Acclarent Aera, Acclarent Navwire |
| Integra Lifesciences Corporation | $316.89 | 2024-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Alk-Abello, INC | $167.03 | 2020-2025 | Grastek, Odactra, Ragwitek |
| Aerin Medical INC. | $128.16 | 2019-2025 | |
| Medtronic, INC. | $123.26 | 2024-2025 | Propel, Sinuva |
| Ars Pharmaceuticals Operations, INC. | $83.83 | 2025 | Neffy |
| Phathom Pharmaceuticals, INC. | $53.38 | 2024-2025 | Voquezna |
| Xoran Technologies LLC | $48.47 | 2019 | |
| Optinose US, INC. | $37.06 | 2020-2025 | |
| Arbor Pharmaceuticals, INC. | $26.40 | 2019 | |
| Phadia US INC. | $26.05 | 2024 | Immunocap |
| Genzyme Corporation | $20.88 | 2021 | |
| Olympus America INC. | $20.19 | 2023 | |
| Hikma Pharmaceuticals USA | $18.61 | 2022 | |
| Boston Scientific Corporation | $18.00 | 2023 | Wavewriter Alpha Prime 16 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $17.93 | 2021 | |
| Kaleo, INC. | $17.21 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $15.63 | 2025 | |
| Merck Sharp & Dohme LLC | $13.35 | 2021 | |
| Stryker Corporation | $11.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.